There has been considerable public and scientific interest in the use of dietary components to prevent or treat human diseases such as cancer, diabetes, cardiovascular and neurodegenerative diseases (
Liu, 2004;
Mattson and Cheng, 2006). Due to the increasing number of phytochemicals being identified and characterized, and the space limitations of this article, we would like to highlight the biological properties of several compounds that are of particular interest from the perspective of hormesis, but have not yet received widespread attention. Many of the phytochemicals that have recently been reported to exert neuroprotective effects in various experimental models of neurological disorders, were previously shown to have cytostatic or cytotoxic effects on cancer cells. These kinds of historical data emphasize the hormetic nature of the neurobiological activities of these phytochemicals.
Chalcone, an α, β-unsaturated aromatic ketone is present in
Angelica keiskei Koidzumi, a plant traditionally used in Japanese’s cuisine (
Akihisa et al., 2003). Chalcone and its derivatives allegedly possess antibacterial, anti-fungal, anti-tumor, and anti-inflammatory activities. Some of the mechanisms underlying chalcone properties are only now being discovered. For example, the anti-inflammatory effects of chalcones rely on their ability to regulate nitric oxide (NO) and cytokine production in macrophages (
Alcaraz et al., 2004;
Ban et al., 2004), as well as to prevent tumor necrosis factor-α (TNF-α) and lipopolysaccharide (LPS)-induced neutrophil adhesion (
Madan et al., 2000). In addition, it has also been shown that chalcone suppresses the activity of cycloxygenase-2 and 5-lipoxygenase (
Araico et al., 2006). In experimental models chalcone administration inhibits chemically-induced pulmonary and mammary carcinogenesis (
Wattenberg et al., 1994). Chalcone derivatives show anti-tumor activity in vitro (
Ye et al., 2004;
Ye et al., 2005).
Nishimura et al., (2007) reported that two chalcone derivatives, isobavachalcone and xanthoangelol H, exhibit high cytotoxicity against neuroblastoma cell lines IMR-32 and NB-39 by activating a pathway involving caspases 9 and 3. However, neither compound had a detrimental effect on normal cerebellar granule cells at the same concentrations tested, thus offering the possibility to use this natural compound as an efficacious and safe potential treatment against neuroblastoma.
Ferulic acid (FA) is a phytochemical commonly found in fruits and vegetables such as tomatoes, sweet corn and rice (
Srinivasan et al., 2007). FA is a phenolic compound with three distinctive structural motifs that can possibly contribute to its free radical scavenging capability (
Srinivasan et al., 2007). It has been reported that FA decreases the levels of inflammatory mediators (prostaglandin E2 and TNF-α;
Ou et al., 2003), and nitric oxide synthase (iNOS) expression and function (
Tetsuka et al., 1996). In addition, hydrophobic ester derivatives of FA seem to have enhanced inhibitory activity on iNOS protein expression in LPS/interferon- γ (IFN-γ) activated RAW264.7 cells (
Murakami et al., 2002). These findings suggest that FA and its esters might be potential anti-inflammatory drugs. Studies have shown that FA exhibits anti-carcinogenic effects against azoxymethan-induced colon carcinogenesis in F344 rats (
Kawabata et al., 2000). It has also been reported to depress 12-O-tetradecanoylphorbol-13-acetate (TPA)-promotion of skin tumorigenesis (
Asanoma et al., 1993). Recently
Sultana et al., (2005) showed that 10–50 □M of FA significantly protects against amyloid beta-peptide (A□) toxicity by modulating oxidative stress and by inducing the expression of protecting proteins in hippocampal cultures. In vivo, long term administration of FA effectively protects against A□ (1-42) toxicity by inhibiting microglial activation (
Kim et al., 2004).
The consumption of green tea has recently attracted much attention in the occidental culture because of its beneficial health effects. The polyphenolic compounds found in green tea include epigallocatechin-3-gallate (EGCG), epicatechin-3-gallate (ECG), epigallocatechin (EGC) and epicatechin (EC), and their intake has been associated with reduced risk of coronary artery disease (
Miura et al., 2001). EGCG is the most abundant and active catechin derivative, and has been shown to possess both anti-inflammatory and anti-atherogenic properties in experimental studies conducted
in vitro and
in vivo (
Hayek et al., 1997;
Tedeschi et al., 2002). A recent study reports that EGCG up-regulates hemeoxygenase-1 (HO-1) expression by activation of the Nrf2/ARE pathway in endothelial cell, conferring resistance against H
2O
2-induced cell death (
Wu et al., 2006), suggesting a hormetic mechanism of action.
Luteolin (3′,4′,5′,7′-tetrahydroxyflavone) is a widespread flavonoid aglycon structurally related to quercetin. Topical application of luteolin causes significant reduction of skin tumor incidence and multiplicity in a mouse skin cancer model (
Ueda et al., 2003). In cell culture studies, luteolin has been shown to be a potent inhibitor of cyclin-dependent kinases, to induce cell cycle arrest in human melanoma cells and apoptotic cell death in human myeloid leukemia cells (
Huang et al., 1999;
Ko et al., 2002). Luteolin also sensitizes cancer cell lines to TNFα-dependent apoptosis by inhibiting the NF-κB pathway (
Shi et al., 2004). In addition to the anticancer properties luteolin has also shown to protect neuronal cell lines against H
2O
2 induced oxidative damage (
Dajas et al., 2003) as well as N-methyl-4-phenyl-pyridinium (MPP+) induced toxicity (
Wruck et al., 2007). In the MPP+ model the ERK-dependent Nrf2 activation is necessary for the beneficial effect of luteolin (
Wruck et al., 2007).
Phenethyl isothiocyanate (PEITC) occurs naturally in cruciferous vegetables such as chinese cabbage, turnips, rutabagas, watercress and radishes (
Tookey et al., 1980;
Carlson et al., 1981;
Sones et al., 1984). PEITC is liberated from its glucosinolate precursor gluconasturtiin by hydrolysis following disruption of the plant tissue and liberation of the plant enzyme myrosinase (
Tookey et al., 1980). PEITC has been shown to inhibit the tumorigenic effects of various carcinogens. Induction of mammary tumors by 7,12-dimethylbenz[a]anthracene in Sprague-Dawley rats is inhibited by pretreatment with PEITC (
Wattenberg, 1977). Dietary PEITC inhibits tomach and pulmonary adenomas induced by 7,12-dimethylbenz[a]anthracene in ICR/Ha mice (
Wattenberg, 1977). Pretreatment with PEITC inhibits lung tumors induced by the tobacco-specific nitrosamine 4-(methylnitrosamino)-l-(3-pyridyl)-1-butanone (NNK) in F344 rats and in A/J mice (
Morse et al., 1989a;
Morse et al., 1989b). It is well documented that in rodents aryl isothiocyanates exert chemopreventive effects against lung (
Morse et al., 1989a;
Jiao et al., 1994;
Nishikawa et al., 1996), esophagus (
Morse et al., 1993;
Stoner et al., 1998), mammary (
Wattenberg, 1992) and stomach (
Wattenberg, 1992) carcinogenesis. PEITC significantly inhibits pancreatic carcinogenesis in hamsters (
Nishikawa et al., 1996). It has also been reported that synthetic analogues of PEITC with longer and modified alkyl chains [e.g. 3- phenylpropyl isothiocyanate (PPITC) and 4-phenylbutyl isothiocyanate (PBITC)] have increased ability to reduce DNA alkylation, and tumor inhibition efficacy than PEITC (
Morse et al., 1989a;
Jiao et al., 1994;
Nishikawa et al., 1996;
Son et al., 2000).
Piceatannol (trans-3,4,3′,5′-tetrahydroxystilbene) isolated from the seeds of
Euphorbia lagascae, is a structural homolog of resveratrol (
Ferrigni et al., 1984). Piceatannol (PIC) is an anti-inflammatory, immunomodulatory and anti-proliferative compound. PIC treatment attenuates the intracellular accumulation of ROS induced by treatment of PC12 cells with Aβ, and inhibits Aβ-induced apoptosis (
Kim et al., 2007). The protective effect afforded by PIC is reportedly stronger than the effect of resveratrol (
Kim et al., 2007). It has also been reported that PIC inhibits the release of NO, PGE2 and pro-inflammatory cytokines in a dose-dependent manner (
Jin et al., 2006).